Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Amazon’s Strategic Pivot in AI Chip Development

Dieter Jaworski by Dieter Jaworski
December 9, 2025
in AI & Quantum Computing, Analysis, Nasdaq, Semiconductors, Tech & Software
0
Amazon Stock
0
SHARES
32
VIEWS
Share on FacebookShare on Twitter

Amazon is accelerating its efforts in the artificial intelligence arena with a significant supply chain shift. Reports indicate the tech behemoth is changing partners for its next-generation AI processors, a move aimed at challenging Nvidia’s dominance and reducing costs. As investors assess the implications of this aggressive realignment, a key consideration is whether the stock’s recent consolidation phase presents a compelling entry point.

Unprecedented Capital Commitment

The scale of Amazon’s ambition is underscored by a monumental capital expenditure plan. For the 2025 fiscal year, the company has budgeted approximately $125 billion for CapEx. The vast majority of this capital is earmarked for expanding capacity and deploying new server infrastructure, a critical foundation for its cloud division, AWS. AWS itself reported revenue growth of roughly 18 percent in the third quarter, highlighting the strategic importance of these investments.

Shifting the Supply Chain for Trainium Chips

At the heart of this strategic shift is Amazon’s “Trainium” AI chip program. According to an analysis by Benchmark Equity Research, Amazon is reassigning the design work for its upcoming Trainium3 and Trainium4 chips. The company is moving this business from its long-time collaborator, Marvell Technology, to competitor Alchip. The announcement had an immediate market impact, sending Marvell’s share price lower on Monday and clearly signaling Amazon’s intensified focus on controlling its AI destiny.

This partner change is fundamentally about supply chain optimization. Amazon’s objectives are twofold: to accelerate the deployment of its proprietary AI infrastructure and to achieve meaningful cost reductions. The overarching goal is to mount a serious challenge to Nvidia’s commanding position in the data center market by offering powerful, cost-effective alternatives for training large language models.

Should investors sell immediately? Or is it worth buying Amazon?

Wall Street’s Bullish Stance Amid Technical Pullback

Despite the aggressive strategic push, Amazon’s shares have recently entered a cooling-off period. Currently trading around €194.80, the stock sits slightly below its 50-day moving average. This technical retracement follows an overheated rally in early November. However, the prevailing view on Wall Street interprets this not as a reversal but as a healthy consolidation within a sustained upward trend.

Market experts maintain a strongly optimistic outlook:
* Evercore ISI increased its price target to $335, suggesting substantial upside potential.
* Susquehanna reaffirmed its positive rating with a $300 target.
* The broad analyst consensus remains a “Strong Buy,” with 43 out of 44 covering analysts recommending purchase.

Conclusion: Efficiency Over Established Ties

Amazon’s supply chain reorganization demonstrates that management prioritizes efficiency and speed over longstanding partnerships in the AI arms race. While the massive $125 billion investment plan will pressure short-term cash flow, the strategic move to vertically integrate chip design and the robust, ongoing growth of AWS indicate that the company’s fundamental growth narrative remains firmly intact.

Ad

Amazon Stock: Buy or Sell?! New Amazon Analysis from February 7 delivers the answer:

The latest Amazon figures speak for themselves: Urgent action needed for Amazon investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Amazon: Buy or sell? Read more here...

Tags: Amazon
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
Next Post
Tilray Stock

Tilray Shares Face Renewed Pressure as Analyst Slashes Price Target

Coinbase Stock

Coinbase Charts a Return to the Indian Market Amid Stock Volatility

Robinhood Stock

Robinhood Targets Southeast Asian Growth with Strategic Acquisitions and Crypto Expansion

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com